A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial
Daren K. Heyland(Queen's University), Oscar Hoiting(Canisius-Wilhelmina Ziekenhuis), Jeroen Schouten(Radboud University Nijmegen), Randy Brown, T. Grau Carmona(Hospital Universitario 12 De Octubre), Arthur R. H. van Zanten(Ziekenhuis Gelderse Vallei), David C. Evans(The Ohio State University), Albertus Beishuizen(Medisch Spectrum Twente), David J. Klein(University of Toronto), A.M. De los Rios Perez(Pivotal (Spain)), J S James, M. Scott Harris(Altimmune (United States)), Kenneth Krell(Eastern Idaho Technical College), Jesús González-Lama(Pivotal (Spain)), María Luisa Bordejé(Hospital Universitari Germans Trias i Pujol)
Cited by 38
Related Papers
ESPEN guideline on clinical nutrition in the intensive care unit
|Clinical Nutrition|2018|2.8k
Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines
|Intensive Care Medicine|2017|816
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
|JAMA|2013|797
Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes
|Cell Reports|2014|678
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648